共 28 条
- [1] Temple RC, Clarke PMS, Hales CN, Measurement of insulin secretion in type 2 diabetes: problems and pitfalls, Diabetic Med, 9, pp. 503-512, (1992)
- [2] Davies MJ, Rayman G., Day JL, Gray IP, Hales CN, Insulin deficiency and increased plasma concentration of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance, Diabetic Med, 10, pp. 313-320, (1993)
- [3] Mitrakou A., Kelley D., Mokan M., Veneman T., Pangburn T., Reilly J., Et al., Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance, N Engl J Med, 326, pp. 22-29, (1992)
- [4] Saad MF, Kahn SE, Nelson RG, Disproportionately elevated proinsulin in Pima Indians with non‐insulin‐dependent diabetes mellitus, The Journal of Clinical Endocrinology & Metabolism, 70, pp. 1247-1253, (1990)
- [5] Gorden P., Hendricks CM, Roth J., Circulating proinsulin‐like component in man: increased proportion in hypoinsulinaemic states, Diabetologia, 10, pp. 469-474, (1974)
- [6] Mako ME, Starr JI, Rubenstein AH, Circulating proinsulin in patients with maturity onset diabetes, Am J Med, 63, pp. 865-869, (1977)
- [7] Williams DRR, Byrne C., Clark PMS, Cox L., Day NE, Hales CN, Et al., Raised proinsulin as an early indicator of b̃ cell function, Br Med J, 303, pp. 95-96, (1991)
- [8] Yoshioka N., Kuzuya T., Matsuda A., Taniguchi M., Iwamoto Y., Serum proinsulin levels at fasting and after glucose load in patients with type 2 (non‐insulin‐dependent) diabetes mellitus, Diabetologia, 31, pp. 355-360, (1988)
- [9] Tillil H., Frank BH, Pekar AH, Broelsch C., Rubenstein AH, Polonsky KS, Hypoglycaemic potency and metabolic clearance rate of intravenously administered human proinsulin and metabolites, Endocrinology, 127, pp. 2418-2422, (1990)
- [10] Galloway JA, Hooper SA, Spradlin CT, Howey DC, Frank BH, Bowsher RR, Et al., Biosynthetic human proinsulin